Publications by authors named "Chikashi Takano"

Introduction: This study examined the efficacy of an 8-week occupational therapy program incorporating mindfulness (MOT) as a form of psychiatric rehabilitation to ameliorate residual social and occupational impairment in patients with anxiety disorders and depression. The objective was to evaluate the effects of MOT on their personal well-being and to assess the impact of MOT on brain function using quantitative electroencephalography (qEEG).

Methods: This study was a randomized, wait-list control trial with assessments performed at baseline, post-intervention (9 weeks), and follow-up (18 weeks) in outpatients with anxiety disorders and depression.

View Article and Find Full Text PDF

Objective: In patients with bipolar disorder (BD), rapid cycling (RC) presents a risk for a more severe illness, while euthymia (EUT) has a better prognosis. This study focused on the progression of RC and EUT, which are contrasting phenomenology, and aimed to clarify the influence of patient backgrounds and prescription patterns on these different progressions, using a large sample from the first and second iterations of a multicenter treatment survey for BD in psychiatric clinics (MUSUBI).

Methods: In the cross-sectional study (MUSUBI), a questionnaire based on a retrospective medical record survey of consecutive BD cases ( = 2,650) was distributed.

View Article and Find Full Text PDF
Article Synopsis
  • A study investigated the effectiveness and safety of asenapine, a medication for schizophrenia, by categorizing patients based on their psychiatric symptoms using a standard assessment called the Positive and Negative Symptom Scale (PANSS).
  • The research involved 529 patients divided into three clusters: those with high positive symptoms (Cluster-P), those with negative symptoms (Cluster-N), and those with generally lower symptoms (Cluster-L).
  • Results showed that both 10 and 20 mg/day of asenapine improved PANSS scores in Clusters-N and-L, while only the 20 mg dose was effective in Cluster-P, indicating that patient symptom backgrounds influence treatment efficacy and safety.
View Article and Find Full Text PDF